Cheil Bio Co

Cheil Bio Co CROIC

Delisted·Feb 25, 2026

The Cash Return on Invested Capital (CROIC) of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is -13.71 %. In the previous year, Cash Return on Invested Capital (CROIC) was 23.32 % — a change of -158.78% (lower).

CROIC

-13.71 %

YoY

-158.78%

Last updated:

Cash Return on Invested Capital (CROIC) of Cheil Bio Co is 2023 -13.71 % . Cash Return on Invested Capital (CROIC) of Cheil Bio Co was 2022 23.32 % . It decreases by -158.78% lower compared to the previous year.

The Cheil Bio Co CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2016
0.57 KRW
Jan 1, 2017
10.04 KRW
Jan 1, 2018
-12.60 KRW
Jan 1, 2019
15.80 KRW
Jan 1, 2020
-8.49 KRW
Jan 1, 2021
-0.45 KRW
Jan 1, 2022
23.32 KRW
Jan 1, 2023
-13.71 KRW
The Cheil Bio Co CROIC history
YEARCROICYoY
-13.71 %-158.78%
23.32 %-5,265.97%
-0.45 %-94.68%
-8.49 %-153.74%
15.80 %-225.39%
-12.60 %-225.55%
10.04 %+1,662.69%
0.57 %-126.27%
-2.17 %-60.40%
-5.47 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

Cash Return on Invested Capital (CROIC) of Cheil Bio Co is -13.71 % in 2023.

Cash Return on Invested Capital (CROIC) of Cheil Bio Co changed from 23.32 % to -13.71 %, representing a -158.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Cheil Bio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Cheil Bio Co

All Key Metrics — Cheil Bio Co